Clinical predictors of delayed cerebral ischemia after subarachnoid hemorrhage: First experience with coil embolization in the management of ruptured cerebral aneurysms

Journal of NeuroInterventional Surgery

Volumn 3, Issue 4, 2011, Pages 344-347

  Kawabata, Yasuhiro ^a,c   Horikawa, Fumihiko ^a   Ueno, Yasushi ^b   Sawada, Masahiro ^a   Isaka, Fumiaki ^a   Miyake, Hidenori ^a  

^a HAMAMATSU ROSAI HOSPITAL   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEURYSM CLIP; ARTICLE; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN ISCHEMIA; COIL EMBOLIZATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HYDROCEPHALUS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RANKIN SCALE; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 81155137249     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/jnis.2010.004077     Document Type: Article

References (29)

1. Charpentier C, Audibert G, Guillemin F, et al. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 1999;30:1402-8. (Pubitemid 29296068)
2. Vergouwen MD, de Haan RJ, Vermeulen M, et al. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke 2009;41:e47-52.
3. Sen J, Belli A, Albon H, et al. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol 2003;2:614-21.
4. Schmidt JM, Wartenberg KE, Fernandez A, et al. Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J Neurosurg 2008;109:1052-9.
5. Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267-74. (Pubitemid 35284616)
6. Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005;366:809-17. (Pubitemid 41557380)
7. Natarajan SK, Sekhar LN, Ghodke B, et al. Outcomes of ruptured intracranial aneurysms treated by microsurgical clipping and endovascular coiling in a high-volume center. AJNR Am J Neuroradiol 2008;29:753-9. (Pubitemid 351571561)
8. Yalamanchili K, Rosenwasser RH, Thomas JE, et al. Frequency of cerebral vasospasm in patients treated with endovascular occlusion of intracranial aneurysms. AJNR Am J Neuroradiol 1998;19:553-8. (Pubitemid 30422769)
9. Murayama Y, Malisch T, Guglielmi G, et al. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases. J Neurosurg 1997;87:830-5.
10. Rabinstein AA, Pichelmann MA, Friedman JA, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg 2003;98:319-25. (Pubitemid 36151027)
11. Dumont AS, Crowley RW, Monteith SJ, et al. Endovascular treatment or neurosurgical clipping of ruptured intracranial aneurysms: effect on angiographic vasospasm, delayed ischemic neurological deficit, cerebral infarction, and clinical outcome. Stroke 2010;41:2519-24.
12. Black PM. Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysms. Neurosurgery 1986;18:12-16.
13. de Oliveira JG, Beck J, Setzer M, et al. Risk of shunt-dependent hydrocephalus after occlusion of ruptured intracranial aneurysms by surgical clipping or endovascular coiling: a single-institution series and meta-analysis. Neurosurgery 2007;61:924-34.
14. Dorai Z, Hynan LS, Kopitnik TA, et al. Factors related to hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003;52:763-9.
15. Tanaka A, Kimura M, Nakayama Y, et al. Cerebral blood flow and autoregulation in normal pressure hydrocephalus. Neurosurgery 1997;40:1161-5.
16. Del Bigio MR. Neuropathological changes caused by hydrocephalus. Acta Neuropathol 1993;85:573-85. (Pubitemid 23212023)
17. van Asch CJ, van der Schaaf IC, Rinkel GJ. Acute hydrocephalus and cerebral perfusion after aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2009;31:67-70.
18. Chou SH, Smith EE, Badjatia N, et al. A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke 2008;39:2891-3.
19. Gruber A, Ungersbock K, Reinprecht A, et al. Evaluation of cerebral vasospasm after early surgical and endovascular treatment of ruptured intracranial aneurysms. Neurosurgery 1998;42:258-67.
20. Naidech AM, Bendok BR, Bassin SL, et al. Classification of cerebral infarction after subarachnoid hemorrhage impacts outcome. Neurosurgery 2009;64:1052-7.
21. Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebocontrolled trial. Stroke 2005;36:1627-32. (Pubitemid 41098752)
22. Rinkel GJ, Feigin VL, Algra A, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2005;1:CD000277.
23. Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 2005;36:2024-6. (Pubitemid 41266547)
24. Munakata A, Ohkuma H, Nakano T, et al. Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2009;64:423-9.
25. Dorhout Mees SM, van den Bergh WM, Algra A, et al. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;4: CD006184.
26. Bilginer B, Onal MB, Narin F, et al. The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model. Turk Neurosurg 2009;19:374-9.
27. Yoshimoto T, Shirasaka T, Fujimoto S, et al. Cilostazol may prevent cerebral vasospasm following subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 2009;49:235-40.
28. Yamaguchi-Okada M, Nishizawa S, Mizutani A, et al. Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model. Cerebrovasc Dis 2009;28:135-42.
29. Ito H, Fukunaga M, Suzuki H, et al. Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: evaluation using black blood magnetic resonance imaging. Neurobiol Dis 2008;32:157-61.